Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)verified

EGTX.ST

Price:

$4.635

Market Cap:

$1.66B

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics...[Read more]

Industry

Biotechnology

IPO Date

2011-04-07

Stock Exchange

STO

Ticker

EGTX.ST

The Dividend Yield as of December 2025 (TTM) for Egetis Therapeutics AB (publ) (EGTX.ST) is 0%

According to Egetis Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Egetis Therapeutics AB (publ) (EGTX.ST) Historical Dividend Yield (quarterly & annually)

How has EGTX.ST Dividend Yield performed in the past?

The mean historical Dividend Yield of Egetis Therapeutics AB (publ) over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), EGTX.ST's Dividend Yield was at its highest in in the December 2015 quarter at 0%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Egetis Therapeutics AB (publ) (EGTX.ST) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Egetis Therapeutics AB (publ) Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20240%0%
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%

Egetis Therapeutics AB (publ) (EGTX.ST) Average Dividend Yield

How has EGTX.ST Dividend Yield performed in the past?

The current Dividend Yield of Egetis Therapeutics AB (publ) (EGTX.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Egetis Therapeutics AB (publ) (EGTX.ST) Dividend Yield vs. Peers

How is EGTX.ST’s Dividend Yield compared to its peers?

Egetis Therapeutics AB (publ)’s Dividend Yield is less than BioInvent International AB (publ) (0%), less than Vicore Pharma Holding AB (publ) (0%), less than Saniona AB (publ) (0%), less than Hansa Biopharma AB (publ) (0%), less than Diamyd Medical AB (publ) (0%), less than Oncopeptides AB (publ) (0%), less than Humana AB (publ) (2.13%), less than SynAct Pharma AB (0%), less than Devyser Diagnostics AB (publ) (0%), less than Xspray Pharma AB (publ) (0%),

Build a custom stock screener for Egetis Therapeutics AB (publ) (EGTX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Egetis Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Egetis Therapeutics AB (publ) (EGTX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Egetis Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Egetis Therapeutics AB (publ)'s Dividend Yield?

How is the Dividend Yield calculated for Egetis Therapeutics AB (publ) (EGTX.ST)?

What is the highest Dividend Yield for Egetis Therapeutics AB (publ) (EGTX.ST)?

What is the 3-year average Dividend Yield for Egetis Therapeutics AB (publ) (EGTX.ST)?

What is the 5-year average Dividend Yield for Egetis Therapeutics AB (publ) (EGTX.ST)?

How does the current Dividend Yield for Egetis Therapeutics AB (publ) (EGTX.ST) compare to its historical average?